Results 231 to 240 of about 163,010 (261)
Some of the next articles are maybe not open access.
Donanemab in Early Alzheimer’s Disease
New England Journal of Medicine, 2021Alette M Wessels +2 more
exaly
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Nature Reviews Drug Discovery, 2010Harald Hampel +2 more
exaly
Drug repositioning for Alzheimer's disease
Nature Reviews Drug Discovery, 2012Anne Corbett +2 more
exaly
Alzheimer's disease: strategies for disease modification
Nature Reviews Drug Discovery, 2010Martin Citron, Citron Martin
exaly
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
New England Journal of Medicine, 2012Randall J Bateman +2 more
exaly
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease
Nature Reviews Drug Discovery, 2013Paul S Aisen +2 more
exaly